As of Oct 06
| +0.36 / +3.15%|
The 8 analysts offering 12-month price forecasts for Mesoblast Ltd have a median target of 19.84, with a high estimate of 52.00 and a low estimate of 8.83. The median estimate represents a +68.29% increase from the last price of 11.79.
The current consensus among 9 polled investment analysts is to Buy stock in Mesoblast Ltd. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.